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dvances in the therapeutic options for cardiovascular
isease, coupled with improvements in imaging technology,
ave led to an explosive growth in the performance of
ardiovascular imaging. Yet this growth is challenging to
nterpret as it may represent appropriate use, underuse (i.e.,
he failure to provide services from which the patient would
ikely benefit), and/or overuse (i.e., the provision of services
hat may not be necessary or may expose the patient to
reater potential harm than benefit).
The array of noninvasive cardiovascular diagnostic tools
as expanded in recent years with innovations in contrast
gents, molecular targeted radionuclides for positron emis-
ion tomography (PET) and single-photon emission com-
uted tomography (SPECT) imaging, perfusion echocar-
iography, cardiac computed tomography (coronary
ngiography and calcium scoring), and cardiac magnetic
esonance imaging (myocardial structure and viability).
urrent patterns of utilization are characterized not only by
rowth but also by significant regional variation (1). Faced
ith uncertainties about the true nature of current utiliza-
ion rates and patterns, clinicians, payers, and patients are
emanding criteria to evaluate the “appropriateness” of
ardiovascular imaging (2).
Ideally, such criteria would arise from high-quality re-
earch evaluating the benefits and risks of performing
maging studies for various common clinical scenarios.
dditionally, a complete evaluation of appropriateness
ight also include a comparison of the relative marginal
ost and benefits of each imaging modality. Regrettably,
here is currently insufficient evidence to make such evalu-
tions across a broad spectrum of potential clinical indica-
ions and/or imaging modalities.
In the absence of ideal evidence for judging the appro-
riateness of interventions, the American College of Car-
iology Foundation (ACCF) Appropriateness Criteria
orking Group proposes a method for evaluating the
ppropriateness of cardiovascular imaging that examines the
ppropriateness of a single modality.
efining Appropriateness
espite the clear need, there is no consensus on how to
etermine the appropriateness of an imaging study. A group
f
s
(
a
i
c
i
p
d
a
g
p
t
m
t
q
p
S
d
h
a
r
a
a
c
j
T
i
b
l
s
a
p
a
p
s
d
p
i
w
i
f
c
a
p
f
q
i
u
t
s
a
i
i
p
fi
p
T
A
b
A
A
m
c
i
a
r
r
f
a
q
1
d
n
e
d
p
2
c
a
1607JACC Vol. 46, No. 8, 2005 Patel et al.
October 18, 2005:1606–13 ACCF Appropriateness of Cardiovascular Imaging: Methodsrom the RAND Corporation, in collaboration with re-
earchers from the University of California, Los Angeles
UCLA), initially described a method for determining the
ppropriateness of medical and surgical procedures, includ-
ng cardiovascular procedures (3–8). However, unlike pro-
edures where there is a defined therapeutic benefit, imag-
ng studies are performed with different goals in mind. The
otential purposes of cardiovascular imaging include the
etection or exclusion of disease, as well as risk stratification
nd the evaluation of therapeutic efficacy. Each of these
oals is tied to specific clinical situations and often includes
atient-level factors and test characteristics associated with
he imaging modality. For example, certain imaging goals
ay favor specific test characteristics, such as highly sensi-
ive tests for the exclusion of disease.
Additionally, imaging studies may have negative conse-
uences, such as poor specificity with a high number of false
ositives leading to unwarranted further procedures or tests.
uch risks and costs are generally not factored into the
efinition of procedural appropriateness, yet these factors
ave an obvious impact upon selecting an imaging modality
nd determining whether it is needed. Inaccurate test results
epresent true risks to the patient and costs to both patients
nd the health care system. Furthermore, cost consider-
tions are often implicitly factored into decisions during
linical care once the added incremental benefit to clinical
udgment of an imaging procedure has been determined.
herefore, to identify the true risks of imaging, both
nherent risks and downstream effects, including costs, must
e considered. As such, if the imaging study provides
ittle incremental information for an indication over
tandard clinical judgment and care, then cost consider-
tions should contribute to deeming the procedure inap-
ropriate. In this manner, a determination of appropri-
teness should aim to overtly replicate the clinical care
rocess of benefit and risk assessment for an imaging
tudy.
Finally, it was believed that the perspective for the
etermination of appropriateness should be that of the
atient. The evaluation should seek to determine how the
nformation gained from the cardiovascular imaging study
ill influence subsequent care to improve patient outcomesFigure 1. Definition of appropriatenncluding survival and health status (a patient’s symptoms,
unction, and quality of life). These issues demand modifi-
ations to the traditional definition used for procedural
ppropriateness.
In summary, a definition of an imaging test’s appro-
riateness must include test performance characteristics
or a clinical indication, the potential negative conse-
uences of imaging, an understanding of the implicit
mpact of cost on clinical decision making, and an explicit
nderstanding of how the test results might lead to care
hat could improve the patient’s chances for better
urvival or improved health status. With these consider-
tions in mind, a definition of appropriate cardiovascular
maging is presented in Figure 1. Simply stated, the goal
s to determine whether an experienced, evidence-based
hysician, faced with a specific clinical situation, would
nd performing the imaging study an acceptable step in
roviding good clinical care.
he RAND/UCLA Appropriateness Method
side from the shortcomings of the invasive procedure-
ased appropriateness definition, the overall RAND/UCLA
ppropriateness Method (Fig. 2) has many merits. The
merican College of Radiology (ACR) has applied the
odified Delphi method used in the RAND/UCLA pro-
ess in the development of appropriateness criteria for
maging. Members of the ACR panels review the appropri-
teness of multiple imaging modalities over numerous
ounds to arrive at consensus recommendations of the
elative benefits and risks of selecting one test over another
or specific clinical indications (9–13). However, the current
pproach used by the ACR still leaves the following
uestions unanswered.
. Multiple goals of imaging. The ACR criteria for car-
iovascular indications focus on primarily obtaining a diag-
osis based on symptoms of indeterminate origin. As stated
arlier, cardiovascular imaging goals extend beyond the
etection of disease to risk assessment and influence on
atient management.
. Acute diagnosis versus disease management. The ACR
riteria focus on a limited number of topics that tend to be
cute presentations with the goal of diagnosis. Managementess for cardiovascular imaging.
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ACCF Appropriateness of Cardiovascular Imaging: Methods October 18, 2005:1606–13f patients with cardiovascular disease often involves evalu-
tion of patients with previously known disease, such as
hronic stable angina. The longitudinal obligation of the
ardiovascular specialist to care for patients creates a need to
onitor for important changes in patients’ disease status
nd/or risk for adverse outcomes over time.
. Context of patient history and physical examina-
ions. Generally, ACR criteria address broad patient indi-
ations absent of the context of a patient history or physical
xamination. The role of pre-test probability or risk is not
ddressed. As such, imaging tests that provide a preliminary
asic assessment of the patient may be unnecessary and may
uplicate later tests that are required and are more appro-
riate given needed therapeutic interventions for a particular
atient’s clinical situation.
. Repeat testing and asymptomatic patients. Care of
he cardiovascular patient includes the important clinical
ituations of identifying an adverse prognosis in asymptom-
tic patients and monitoring correctly diagnosed and treated
atients over time. These were not explicitly performed with
he ACR appropriateness criteria.
. Selection among modalities versus appropriateness of
single modality. Although selection among multiple mo-
alities is important, specific clinical scenarios and local con-
itions such as technical skill level and laboratory qualities
ften influence the initial test choice. Ranking the different
odalities without this specific information is difficult. While
omparisons across modalities should be done, the first step is
o define appropriateness within each modality.
. Achieving consensus. The ACR uses up to four rounds
igure 2. The RAND method with modified Delphi process for appropria
l. The RAND/UCLA Appropriateness Method User’s Manual. Santa Mf rating, if necessary, to attain consensus. The ACCF use ef the RAND/UCLA method, which is limited to two
ounds of ratings, does not try to promote consensus and
otentially reduce the real differences of clinical opinion that
ay underlie indications rated as uncertain.
The Working Group recommends use of the RAND/
CLA Appropriateness Method with a focus on answering
he questions in the preceding text. To do so effectively, the
orking Group determined it would be best to rate
ppropriateness one modality at a time (Fig. 3). This
ocument addresses how one might then choose among
ifferent imaging modalities, deemed appropriate for an
ndividual indication, so as to ensure efficient imaging. The
teps of the RAND/UCLA Appropriateness Method, as
hey are proposed to be applied to imaging, are outlined in
he following text.
tep 1: Indication Development and Literature Re-
iew. The first step requires reviewing the literature and
eveloping the clinical indications to be rated. As men-
ioned, for cardiovascular imaging, imaging studies may be
erformed for diagnosis, risk stratification and prognosis,
herapeutic management decisions, or simply to exclude
isease. Therefore, the indications to be rated for each
odality should capture the general presenting symptoms,
he clinical reason for imaging, the patient population, and
ther specific factors. Additionally, the list of clinical indi-
ations must be exclusive of other clinical indicators and
epresent common practice indications. The clinical indica-
ion list also should attempt to include clinical scenarios for
hich there is practice variation. Health plans and employ-
s. (Adapted with permission from Fitch K, Bernstein SJ, Aguilar MD, et
, CA: The RAND Corporation, 2001.)rs may also be able to provide additional data on high-
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October 18, 2005:1606–13 ACCF Appropriateness of Cardiovascular Imaging: Methodsolume clinical indications to be considered in developing a
omprehensive list.
Ideally, the clinical indications would be developed by a
ew general cardiovascular clinicians and by specialists in the
maging modality being evaluated. Indications may be in
art derived from existing guidelines for cardiovascular
maging modalities, where available. However, common
cenarios not included in the guidelines should be incorpo-
ated in an effort to assess appropriateness.
Next, a standardized literature review should be initiated
or the clinical indications, as currently performed in the
evelopment of the American College of Cardiology/
merican Heart Association (ACC/AHA) clinical practice
uidelines (14). As suggested by the RAND methodology,
evidence tables” should be formed when significant evi-
ence is available for a specific indication or set of indica-
ions. Because the majority of imaging studies have incor-
orated observational cohort designs, particular emphasis
hould be placed on identifying common sources of bias,
uch as referral bias, selected populations, and blinding
15). Many of these are incorporated into the Standards
or Accurate Reporting of Diagnostic studies (STARD)
nitiative checklist (16). The ACC/AHA guidelines also
an be useful sources of literature reviews related to most
ardiovascular imaging modalities (17,18).
tep 2: Expert Panel Rating. The second step for deter-
ining the appropriateness of a cardiovascular imaging
odality is review of the clinical indications by an expert
anel. It is recommended that the expert panel consist of 9
o 15 people, ideally including physicians from different
pecialties, experts in different imaging modalities, general
ardiovascular and other medical practitioners who often
rder such imaging studies, payers, and health services
esearchers. This type of diverse panel composition helps to
nsure the production of equitable and reproducible ratings
19–21).
Each panelist should then complete a first round of
atings to provide indications in isolation and without
Figure 3. Overview of cariscussion with other participants on the panel. The panel- ssts assign the ratings to each indication based on the
ollowing scoring system:
edian score 7 to 9: Appropriate test for that specific
ndication (test is generally acceptable and is a reasonable
pproach for the indication).
edian score 4 to 6: Uncertain or possibly appropriate test
or that specific indication (test may be generally acceptable
nd may be a reasonable approach for the indication).
ncertainty also implies that more research and/or patient
nformation is needed to classify definitively the indication
s appropriate and to update the criteria.
edian score 1 to 3: Inappropriate test for that indication
test is not generally acceptable and is not a reasonable
pproach for the indication).
The panelists are to rate the appropriateness of an
ndication based on the available evidence for each specific
ndication. Panelists also should use reproducibility and
atient-specific information in determining the appropri-
teness for each indication (Fig. 4). When available, the
CC/AHA clinical practice guideline recommendations
lso should be included for the panel to review. Although
his information is provided as a guide, it does not dictate a
articular rating of any indication. In addition, where there
s a lack of evidence or guideline, clinical experience forms
he basis for the appropriateness rating.
tep 3: Panel Meeting. Once first round ratings are
omplete, a panel meeting should be convened to discuss
he indication list. At the panel meeting the ratings are
resented as a distribution of scores and a median score.
dditionally, all panel members receive identification of
heir personal score in relation to the distribution. The
urpose of the panel meeting is not to reach consensus
ut to provide panel members an opportunity to share
erspectives. The ratings with significant widespread
istribution identify areas for clarification and serve as
he basis for discussion among members. Importantly,
cular imaging evaluation.ources of disagreement based on misunderstandings of
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ACCF Appropriateness of Cardiovascular Imaging: Methods October 18, 2005:1606–13he indications are addressed by refining the wording of
ndications where required. A second round of rating by
ndividual panel members should occur either at the end
f the face-to-face meeting or during the weeks following
he meeting.
tep 4: Rating Tabulation. The final step is tabulating the
ppropriateness ratings from the second round. Each indi-
ation has been scored by the panel and the median score is
sed to determine the final appropriateness score.
After the second rating round, a procedure to measure
he level of agreement among panelists (e.g., the
IOMED Concerted Action on Appropriateness defini-
ion) is applied to the final ratings. Under the BIOMED
ethod, which is useful for panels with 11 to 13
embers, agreement is defined as three or fewer panelists
ating outside the three-point region containing the
edian. Disagreement is defined as at least 4 panelists
ating in each extreme (1 to 3 and 7 to 9). For those
linical indications for which the panel cannot agree, the
maging study is marked as uncertain for that indication
egardless of the median score.
nterpretation of Appropriateness Scores
nterpretation and context of the final appropriateness
cores are important. Clinicians and payers will be faced
ith a list of clinical indications for a single imaging
odality that are deemed appropriate with scores of 7 to 9,
ncertain with scores of 4 to 6, and inappropriate with
cores of 1 to 3. An uncertain classification generally
ndicates there is not sufficient evidence, experience with the
maging study, or detailed patient characteristics for the
ndication to definitively categorize an imaging procedure as
ppropriate. It does not indicate that the imaging test
hould not be performed in that particular situation, or that
Figure 4. Determining appropriateness shere is no evidence of benefit, but rather that more anformation and/or research could benefit updating the
riteria.
Payers should be aware that the appropriateness determi-
ations provide general criteria for imaging modalities, with
he understanding that clinicians may be faced with unique
ssues regarding individual patients. A consistent pattern of
nappropriate testing by a provider should prompt further
eview. Conversely, providers may also decide not to per-
orm an imaging study that is deemed “appropriate,” and
his may simply relate to different levels of clinical certainty
or specific indications or other factors such as patient
reference. Finally, payers should note that the technical
anel and clinical community do not consider uncertain
ndications as those that should not be performed or
eimbursed, as many may be the standard of care in specific
egions of the country. Rather, the uncertain indications are
hose where the opinions of the panel vary. Indications with
igh clinical volume that are rated as uncertain in the
ppropriateness review may suggest areas for increased focus
nd research. The appropriateness evaluations will also
rovide an opportunity to identify indications for which
umerous modalities are appropriate. These again will be
reas where high-quality clinical trials can improve patient
are and potentially reduce cost.
ppropriateness Criteria in Context
ppropriateness criteria for cardiovascular imaging differ
rom guidelines and performance measures in important
ays. Guidelines attempt to provide a comprehensive review
f the available evidence and best practices for the manage-
ent of a clinical condition such as heart failure. Perfor-
ance indicators capture aspects of care recommended in the
uideline that have been indisputably proven to improve
atient outcomes and for which data can be collected that
guides for panel reviewers to consider.re interpretable, actionable, and feasible (22). In contrast,
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October 18, 2005:1606–13 ACCF Appropriateness of Cardiovascular Imaging: Methodsppropriateness criteria for imaging explicitly evaluate the
elative benefits and risks of an imaging study for a specific
ndication to determine whether it is “reasonable” to con-
ider performing the study.
ontinuing Evaluation of Appropriateness Ratings
oth validation and evaluation of the proposed appropri-
teness ratings by modality are essential steps. The first
valuation should be to determine whether the indications
hosen for a specific modality can be applied. Do the
ndications cover the majority of reasons for which the
maging test is performed? Can the indications be easily
bstracted from current care data? Are they reproducible?
hese types of questions can be addressed by collaboration
ith medical directors, payers, and large clinical practices.
dditionally, the entire appropriateness ratings for a mo-
ality should be evaluated as described by the initial RAND
ethodology with either a retrospective review of previous
maging or with a prospective review of indications for an
maging study to determine the rate of appropriate imaging,
rue positive and true negative rates and, ideally, the
onsequences for patient outcomes.
The Working Group recognizes that the method for
valuating cardiac imaging will continue to adapt and evolve
ith experience and increased national focus. However,
ven with these anticipated changes, the growing demand
or a framework with which to evaluate current patterns of
are warrants proceeding with an initial attempt to define
he issues involved and to provide an initial method for
valuating imaging use. In addition to the results from the
eld testing of appropriateness ratings for a modality, new
vidence in imaging will likely require updates to the
ppropriateness ratings.
uture Directions: Evaluation by Indication
nce the appropriateness evaluation is complete across
ultiple imaging modalities, clinicians and payers will
aturally attempt to compare modalities not only for pre-
ictive accuracy but also for criteria such as cost-
ffectiveness or “efficiency” across similar clinical indica-
ions. These comparisons will be especially challenging as
ssues surrounding each imaging appropriateness review, the
maging test’s specific characteristics, and exact patient
actors for each indication will likely vary substantially for
ach imaging modality.
Nevertheless, efforts to formally evaluate efficient imaging
or specific indications addressed by a single imaging mo-
ality or by multiple modalities are planned. Unfortunately,
n assumed starting point for an evaluation of efficient
maging is absent from current evidence. Explicit standard
cceptable values for true positive and true negative results
rom imaging studies for specific indications have not been
eveloped. As such, an alternative strategy for determining
he efficient imaging utilization is required. Although some
mplicit weighing of costs occurs during the evaluation of
specific imaging modality, more explicit weight can be diven comparing different modalities. A comparison is
ossible where several imaging modalities have been
reviously deemed appropriate. Cost comparison at this
oint may allow the relative weighing of costs per
maging modality with comparative benefits per clinical
ndication, thus providing a measure of efficiency.
As with appropriateness, the initial step in creating
ecommendations of imaging efficiency requires construct-
ng a list of relevant clinical indications. This would include
etermining those common clinical indications for which
here are not sufficient data to recommend a single imaging
trategy. All imaging modalities that were deemed to be
ppropriate for those indications should be evaluated. Cli-
icians and payers should participate in identifying among
hose clinical indications for which there is high clinical
olume and need for efficient imaging recommendations.
The panel that evaluates efficient imaging recommenda-
ions should represent a diverse range of expertise. The
roup should include clinicians with medical expertise in the
rea of the indication, clinicians with imaging expertise for
ll the considered modalities, health service researchers,
ayers, and invasive cardiologists or surgeons if the indica-
ion may lead to a procedure. This group would then score
he various imaging modalities for the specific indication
hrough a modified Delphi process as described previously.
reat care must be undertaken in the selection of panel
embers to avoid an undue bias in favor or against any and
ll imaging procedures.
The method for analysis of efficient imaging will require
ignificant future work. Some potential metrics for analysis
f efficient imaging include test characteristics such as the
elative cost of the different modalities, the relative strength
f test performance characteristics of each imaging modality
ith regards to the specific indication, and the comparative
vailability of evidence for the individual modalities. Unin-
ended consequences for each modality, both additional
ncillary information that may provide the final diagnosis
nd risks from the procedure, should also be considered in
fficiency determination. Moreover, variance in local avail-
bility and quality of various techniques needs to be con-
idered. Finally, consideration of patient preferences and
omfort must be included.
Essential to this type of evaluation are studies comparing
trategies using different imaging modalities that carefully
apture all of these aspects including diagnostic yield, cost,
eproducibility, and downstream patient outcomes. Cur-
ently, the majority of evidence for cardiovascular imaging
escribes the diagnostic yield compared to a reference
tandard, or the prognostic significance of findings from the
maging study.
Few studies exist that randomize patients with specific
resenting symptoms to one diagnostic strategy versus
nother (23). In fact, although other study designs are
ogistically easier, randomized trials evaluating two different
iagnostic strategies may be the best pragmatic way to
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ACCF Appropriateness of Cardiovascular Imaging: Methods October 18, 2005:1606–13etermine the efficiency of different imaging modalities
24).
Thus, the efficient imaging recommendation that pro-
ides a comprehensive evaluation of different cardiovas-
ular imaging modalities for a specific indication, incor-
orating evidence on different test performance, cost, and
ownstream outcomes, remains an important goal. Al-
hough the current available literature may not be suffi-
ient, it is hoped that continued research in cardiovascu-
ar imaging will allow evaluation of efficient imaging in
he future.
onclusions
ardiovascular imaging has enjoyed fantastic technical ad-
ances over the last 25 years. These advances, coupled with
ignificant improvements in the therapeutic options for
atients with heart disease, provide an unparalleled oppor-
unity to decrease the burden of cardiovascular disease.
owever, a great threat to achieving this goal is ther. Michael J. Wolk None Noneulting in substantial, unexplained regional variability and
ncreased attendant costs.
This document provides a framework to determine ap-
ropriate clinical indications for an imaging modality. Ad-
itionally, the future direction for rating the efficiency of
maging for specific indications across single and multiple
ppropriate modalities is discussed. These goals for cardio-
ascular imaging are both economically and clinically criti-
al. Long-term success of such efforts will require high-
uality research for common clinical indications to extend
he evidence base for future panels. Such research will
educe the number of uncertain indications and confirm the
alidity of both appropriate and inappropriate ratings. It is
ith this type of work and ongoing evaluation of cardiovas-
ular imaging that patients and society will truly reap the
enefit from advances in cardiovascular imaging. As such,
he development of appropriateness criteria and efficiency
onsiderations for cardiovascular imaging can serve as an
mportant guide for delivery of high-quality clinical care
ith imaging and provide a structure to evaluate utilization,nappropriate application of these imaging modalities re- including underuse and overuse of current modalities.
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